“5.12”汶川地震部分灾区健康人群流脑抗体水平调查

英文篇名：Level of Antibody Against Epidemic Meningitis In Healthy Population of Wenchuan Earthquake Stricken Region
中文刊名：预防医学情报杂志
英文刊名：Journal of Preventive Medicine Information
作者：高文凤 ; 周子人 ; 曹冉冉 ; 刘衡川
英文作者：GAO Wen-feng1 ; ZHOU Zi-ren2 ; CAO Ran-ran1 ; et al.1 Department of Public Health ; Sichuan University ; Chengdu 610041 ; Sichuan ; China.2 Pixian Center for Disease Control and Prevention ; Chengdu 611730 ; Sichuan ; China.
中文关键词：流行性脑膜炎 ; 抗体水平 ; 汶川地震灾区
英文关键词：epidemic meningiti ; the levels of antibody ; Wenchuan earthquake stricken region
出版日期：2011-08-28
机构：四川大学华西公共卫生学院;成都市郫县疾病预防与控制中心;
年：2011
期：08
出版单位：预防医学情报杂志

摘要

目的了解汶川地震灾区健康人群流行性脑膜炎(流脑)A群、C群抗体水平,为制定预防控制措施提供依据。方法采集灾区灾民安置点中5～年龄组、10～年龄组、15～年龄组及25～年龄组健康人群血液标本293份,应用ELISA试剂盒检测A、C群流脑抗体水平。结果汶川地震灾区健康人群A群流脑抗体总阳性率为82.3%(241/293),抗体含量中位数为4.86μg/ml;C群流脑抗体总阳性率为71.3%(209/293),抗体含量中位数为4.39μg/ml。结论汶川地震灾区健康人群A群、C群流脑抗体水平均处于较高水平。灾区流脑A+C群疫苗加强接种为预防流脑流行发挥了重要作用。
Objective To understand the levels of antibodies A and C groups against epidemic meningitis in healthy population of Wenchuan earthquake stricken region,provide evidence for developing prevention measures against the disease.Methods Totally 293 blood samples of healthy population from settlement in 4 age groups were collected,and ELISA assay kit was applied to test the levels of A and C groups antibodies.Results The total positive rate of A group antibody in healthy population of Wenchuan earthquake stricken region was 82.3% with 4.86 μg/ ml as median of amount,and the total postive rate of C group antibody in healthy population was 71.3% with 4.39 μg/ ml as median of amount.Conclusion Both A and C group antibodies among healthy population in Wenchuan earthquake stricken region are at comparatively high level.Epidemic meningitis A+C group vaccine has exerted a phenomenal efforts on the prevention of epidemic meningitis prevalence.

引文

[1]http://www.moh.gov.cn/publicfiles//business/htmlfiles/wsb/in-dex.htm
    [2]史淑芬,孙穆.北京市西城区年健康人群群、群流脑抗体水平监测[J].首都公共卫生.2007.1(3):132-133.
    [3]廖春艳,吴国辉,李坤碧,等.重庆市健康人群A群C群脑膜炎奈瑟菌抗体水平调查[J].中国计划免疫,2006,12(1):56-58.
    [4]贾有菊.青海省健康人群脑膜炎奈瑟菌带菌和抗体水平调查[J].中国计划免疫,2006,14(5):460.
    [5]吴兴华,林玫,秦卫文,等.2008年广西健康人群流脑带菌和A、C、Y、W135群抗体水平分析[J].应用预防医学,2009,15(6):331-333.
    [6]伏晓庆,尹建雯,高援,等.云南2005年健康人群流脑带菌调查结果分析[J].实用预防医学,2006,13(12):341-342.
    [7]张秋香,郝瑞娥,张凡非,等.2005年山西省健康人群流行性脑脊髓膜炎免疫水平和带菌状况调查[J].预防医学论坛,2008,14(1):29-30.
    [8]刘美珍,杨华可,廖国东,等.2005年广东省健康人群流脑免疫水平和带菌状况调查[J].中国卫生检验杂志,2007,17:325-327.
    [9]周长月,毕诚.江苏省2005年健康人群流行性脑脊髓膜炎监测[J].华南预防医学,2007,33(1):36-38.
    [10]梁士国,李岩,段玉玲,等.哈尔滨市2007年健康人群流脑免疫水平和带菌状况[J].中国热带医学,2009,9(2):342-343.
    [11]原灵,郭维植,董新平,等.福建省2005年流脑带菌率及免疫水平调查[J].海峡预防医学杂志,2006,(12):28-29.